These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3500081)

  • 21. Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.
    Czinn S; Carr H; Aronoff S
    Antimicrob Agents Chemother; 1986 Aug; 30(2):328-9. PubMed ID: 3767346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
    Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
    Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo activity of various antibiotics against Listeria monocytogenes type 4b.
    Hawkins AE; Bortolussi R; Issekutz AC
    Clin Invest Med; 1984; 7(4):335-41. PubMed ID: 6442656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria.
    Derriennic M; Dubreuil L; Reynaud AE; Courtieu AL
    Chemioterapia; 1987 Jun; 6(2 Suppl):159-60. PubMed ID: 3509376
    [No Abstract]   [Full Text] [Related]  

  • 28. In-vitro evaluation of miokamycin: bactericidal activity against streptococci.
    Lacey RW; Lord VL; Howson GL
    J Antimicrob Chemother; 1984 Jan; 13(1):5-13. PubMed ID: 6607918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra.
    Bayer AS; Lam K
    Clin Ther; 1983; 5(4):391-7. PubMed ID: 6871922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sensitivity of Gardnerella vaginalis to antibiotics. Study of 40 strains isolated at the Purpan University Hospital Center of Toulouse].
    Lefevre JC; Prere MF; Lareng MB
    Pathol Biol (Paris); 1983 Jun; 31(6):533-5. PubMed ID: 6348664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructure of Mycoplasma pneumoniae exposed to macrolide antibiotics during cultivation on a glass surface and in an organ culture, in relation to their mycoplasma-killing activity.
    Watanabe T
    Drugs Exp Clin Res; 1988; 14(4):231-51. PubMed ID: 3139385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro brodimoprim activity on bacterial strains.
    Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
    J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Haemophilus vaginalis (Corynebacterium vaginale) by metronidazole, tetracycline, and ampicillin.
    Ralph ED; Austin TW; Pattison FL; Schieven BC
    Sex Transm Dis; 1979; 6(3):199-202. PubMed ID: 388682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semisynthetic derivatives of purpuromycin as potential topical agents for vaginal infections.
    Trani A; Dallanoce C; Panzone G; Ripamonti F; Goldstein BP; Ciabatti R
    J Med Chem; 1997 Mar; 40(6):967-71. PubMed ID: 9083486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.
    Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1983 Aug; 24(2):209-15. PubMed ID: 6638988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH; Houck H
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of antichlamydial effect of rokitamycin].
    Soejima R; Hino J; Nakagawa Y; Kishimoto T; Matsumoto A
    Jpn J Antibiot; 1988 Jul; 41(7):830-5. PubMed ID: 3172456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of Mycobacterium avium to a new macrolide (RU-28965).
    Casal M; Rodriguez F; Villalba R
    Chemotherapy; 1987; 33(4):255-8. PubMed ID: 3608625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
    Varotto F; Garlaschi ML; Garlaschi MC; Falchi M; Scaglione F; Cattaneo G; De Luca M; Fraschini F
    J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of two macrolide antibiotics to prevent post-extraction bacteraemia.
    Cannell H; Kerawala C; Sefton AM; Maskell JP; Seymour A; Sun ZM; Williams JD
    Br Dent J; 1991 Sep; 171(6):170-3. PubMed ID: 1832916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.